Prelude Capital Management, LLC Ark Genomic Revolution ETF (De Transaction History
Prelude Capital Management, LLC
- $1.5 Billion
- Q4 2024
A detailed history of Prelude Capital Management, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Prelude Capital Management, LLC holds 6,600 shares of ARKG stock, worth $145,002. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,600Holding current value
$145,002% of portfolio
0.01%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding ARKG
# of Institutions
282Shares Held
23.4MCall Options Held
2.95MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$79.7 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$76.6 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$61.3 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$61.1 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$36.4 Million0.02% of portfolio